Teva UK introduces first generic oral anticoagulant
Apixaban will be available for the prevention of stroke and deep vein thrombosis
Read Moreby Iona Everson | Jun 1, 2022 | News | 0
Apixaban will be available for the prevention of stroke and deep vein thrombosis
Read Moreby Selina McKee | Dec 7, 2018 | News | 0
UK-based specialty pharma group Mallinckrodt has unveiled plans to spin-off its specialty generics and active pharmaceutical ingredients business into a new company
Read Moreby Selina McKee | Apr 17, 2018 | News | 0
Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).
Read Moreby Selina McKee | Aug 4, 2016 | News | 0
Teva Pharmaceutical Industries has unveiled plans to buy Allergan-owned US generics giant Anda for $500 million.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479